01 6GLOBAL BLOOD THERAPS
01 611020382
01 6Blank
01 6Blank
01 62036-12-02
Patent Expiration Date : 2036-12-02
US Patent Number : 11020382
Drug Substance Claim :
Drug Product Claim :
Application Number : 216157
Patent Use Code : U-3133
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-02
Patent Expiration Date : 2036-12-02
US Patent Number : 11020382
Drug Substance Claim :
Drug Product Claim :
Application Number : 213137
Patent Use Code : U-3133
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-02
Patent Expiration Date : 2036-12-02
US Patent Number : 11020382
Drug Substance Claim :
Drug Product Claim :
Application Number : 213137
Patent Use Code : U-3134
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-02
Patent Expiration Date : 2036-12-02
US Patent Number : 11020382
Drug Substance Claim :
Drug Product Claim :
Application Number : 213137
Patent Use Code : U-3133
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-02
Patent Expiration Date : 2036-12-02
US Patent Number : 11020382
Drug Substance Claim :
Drug Product Claim :
Application Number : 213137
Patent Use Code : U-3134
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-02
Patent Expiration Date : 2036-12-02
US Patent Number : 11020382
Drug Substance Claim :
Drug Product Claim :
Application Number : 216157
Patent Use Code : U-3134
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-02
